BRCA gene testing rates increased by nearly 40 percent in the week of Angelina Jolie’s 2013 announcement that she carried the BRCA 1 gene mutation and had an elective double mastectomy, according to a new AARP Public Policy Institute study released Feb. 11.
An analysis by researchers from the International Agency for Research on Cancer casts doubt on validity of an endpoint used in key studies of multi-cancer detection tests.
